Following President Trump’s meeting with pharmaceutical executives this month, many foreign drug makers have begun planning production sites in the United States. Aurobindo Pharma, an Indian pharmaceutical company is one of these foreign drug makers interested in following Trump’s call to action. Already running one production facility, the pharmaceutical company has plans to locate its second U.S. site near the first in New Jersey. Read the full article here.